Finance

Beta
Lists
VHI:NYSE
Valhi Inc
$14.49
+4.02%
(+0.56) 1D
Jun 4, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VHI...
Open
$14.25
High
$14.82
Low
$14.02
Mkt. cap
410.10M
Avg. vol.
15.51K
Volume
5.00
Dividend
2.21%
Quarterly dividend
$0.08
Ex-dividend date
Jun 4, 2026
52-wk high
$20.00
52-wk low
$11.44
EPS
-$2.54
Beta
0.96
Shares outstanding
28.30M
No. of employees
3K
Open
$14.25
High
$14.82
Low
$14.02
Mkt. cap
410.10M
Avg. vol.
15.51K
Volume
5.00
Dividend
2.21%
Quarterly dividend
$0.08
Ex-dividend date
Jun 4, 2026
52-wk high
$20.00
52-wk low
$11.44
EPS
-$2.54
Beta
0.96
Shares outstanding
28.30M
No. of employees
3K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to VHI in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for VHI in the last 3 months.
Highest
Current $14.49
$7.91 (-45.38%)
Average
$7.91 (-45.41%)
Lowest
$7.91 (-45.38%)
News stories
From sources across the web
Profile
Valhi, Inc. is an American holding company operating through wholly and majority-owned subsidiaries in a number of different industries. It was founded in 1987 as a result of the merger of the LLC Corporation and Amalgamated Sugar Company. The Contran Corporation owned 93% of Valhi's common stock as of December 2014. The chairman of the company was Harold Simmons until his death in 2013. As of 2014 it was a Fortune 1000 company. Wikipedia
About Valhi Inc
CEO-
Employees2.83K
Founded1987
HeadquartersDallas, Texas, United States
SectorSpeciality chemicals
Websitevalhi.net
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.07 / $0.77
-90.94%miss
Revenue / Est. (USD)
560.10M / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
540.40M
503.50M
494.50M
560.10M
Cost of goods sold
462.30M
442.90M
456.40M
457.10M
Cost of revenue
462.30M
442.90M
456.40M
457.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79.90M
78.50M
100.90M
78.30M
Operating expense
79.90M
78.50M
100.80M
72.80M
Total operating expenses
542.20M
521.40M
557.20M
529.90M
Operating income
-1.80M
-17.90M
-62.70M
30.20M
Other non operating income
31.10M
20.60M
300.00K
400.00K
EBT including unusual items
15.50M
-7.60M
-81.70M
14.10M
EBT excluding unusual items
15.50M
-12.20M
-71.20M
14.30M
Income tax expense
8.00M
14.30M
-18.40M
6.30M
Effective tax rate
51.61%
-188.16%
22.52%
44.68%
Other operating expenses
-
-
-100.00K
-5.50M
Net income
900.00K
-22.20M
-53.20M
2.00M
Net profit margin
0.17%
-4.41%
-10.76%
0.36%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4.20M
3.70M
Interest expense
-13.80M
-14.90M
-15.20M
-14.70M
Net interest expenses
-13.80M
-14.90M
-11.00M
-11.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.20M
200.00K
-45.30M
46.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer